Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China
· Delayed Price · Currency is CNY 34.45
-0.62 (-1.77%)
Apr 29, 2026, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 15.12 billion as of April 28, 2026. Its market cap has increased by 88.29% in one year.
Market Cap
15.12B
Enterprise Value
16.74B
Revenue
662.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.45
Market Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 15.12B, an increase of 54.39%. That is a compound annual growth rate of 10.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 15.12B | -1.62% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 15.23B |
| Jinyu Bio-technology | 14.86B |
| Anhui Anke Biotechnology (Group) | 14.80B |
| Inner Mongolia Furui Medical Science | 14.60B |
| Sinocelltech Group | 19.51B |
| InventisBio | 13.27B |
| Staidson (Beijing) BioPharmaceuticals | 13.14B |
| Tibet Cheezheng Tibetan Medicine | 12.84B |